ReP USP - Resultado da busca

Artigo de periodico
PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients (2024)
Almeida, Anderson Rodrigues de ; Dantas, Andréa Tavares; Gonçalves, Maria Eduarda de Oliveira; Chêne, Charlotte ; Jeljeli, Mohamed ; Chouzenoux, Sandrine ; Thomas, Marine; Cunha, Eudes Gustavo Constantino ; Valadares, Lilian David de Azevedo ; Gomes, João Victor de Melo ; Paula, Simão Kalebe Silva de ; Pitta, Marina Galdino da Rocha ; Pitta, Ivan da Rocha ; Rêgo, Moacyr Jesus Barreto de Melo ; Pereira, Michelly Cristiny ; Duarte, Angela Luzia Branco Pinto; Abdalla, Dulcinéia Saes Parra ; Nicco, Carole ; Batteux, Frédéric ; Pitta, Maira Galdino da Rocha
Source: Inflammopharmacology. Unidade: FCF
Subjects: FIBROSE PULMONAR, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Anderson Rodrigues de et al. PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients. Inflammopharmacology, v. 32, p. 433-446, 2024Tradução . . Disponível em: https://doi.org/10.1007/s10787-023-01296-9. Acesso em: 14 jul. 2024.
APA
Almeida, A. R. de, Dantas, A. T., Gonçalves, M. E. de O., Chêne, C., Jeljeli, M., Chouzenoux, S., et al. (2024). PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients. Inflammopharmacology, 32, 433-446. doi:10.1007/s10787-023-01296-9
NLM
Almeida AR de, Dantas AT, Gonçalves ME de O, Chêne C, Jeljeli M, Chouzenoux S, Thomas M, Cunha EGC, Valadares LD de A, Gomes JV de M, Paula SKS de, Pitta MG da R, Pitta I da R, Rêgo MJB de M, Pereira MC, Duarte ALBP, Abdalla DSP, Nicco C, Batteux F, Pitta MG da R. PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients [Internet]. Inflammopharmacology. 2024 ; 32 433-446.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1007/s10787-023-01296-9
Vancouver
Almeida AR de, Dantas AT, Gonçalves ME de O, Chêne C, Jeljeli M, Chouzenoux S, Thomas M, Cunha EGC, Valadares LD de A, Gomes JV de M, Paula SKS de, Pitta MG da R, Pitta I da R, Rêgo MJB de M, Pereira MC, Duarte ALBP, Abdalla DSP, Nicco C, Batteux F, Pitta MG da R. PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients [Internet]. Inflammopharmacology. 2024 ; 32 433-446.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1007/s10787-023-01296-9
Editor de periodico
Brazilian Journal of Pharmaceutical Sciences (2022)
Ferreira, Elizabeth Igne (Editor) ; Rangel-Yagui, Carlota de Oliveira (Editor) ; Serra, Cristina Helena dos Reis (Editor) ; Finardi Filho, Flavio (Editor) ; Martins, Joilson de Oliveira (Editor) ; Gioielli, Luiz Antonio (Editor) ; Vitolo, Michele (Editor); Barros, Silvia Berlanga de Moraes (Editor) ; Storpirtis, Silvia (Editor) ; Maria-Engler, Silvya Stuchi (Editor) ; Consiglieri, Vladi Olga (Editor) ; Andricopulo, Adriano Defini (Editor) ; Midio, Antonio Flavio (Editor); Salatino, Antonio (Editor) ; Abdalla, Dulcinéia Saes Parra (Editor) ; Lajolo, Franco Maria (Editor) ; Lopes, João Luis Callegari (Editor) ; Mancini-Filho, Jorge (Editor) ; Santoro, Maria Inês Rocha Miritello (Editor); Penteado, Marilene de Vuono Camargo (Editor); Yoshida, Massayoshi (Editor); Curi, Rui (Editor) ; Oga, Seizi (Editor); Vilela, Sueli (Editor)
Unidades: FCF, IFSC, IB, FCFRP, IQ
Assunto: FARMÁCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Brazilian Journal of Pharmaceutical Sciences. . São Paulo: Universidade de São Paulo - USP. . Acesso em: 14 jul. 2024. , 2022
APA
Brazilian Journal of Pharmaceutical Sciences. (2022). Brazilian Journal of Pharmaceutical Sciences. São Paulo: Universidade de São Paulo - USP.
NLM
Brazilian Journal of Pharmaceutical Sciences. 2022 ;[citado 2024 jul. 14 ]
Vancouver
Brazilian Journal of Pharmaceutical Sciences. 2022 ;[citado 2024 jul. 14 ]
Artigo de periodico
Ischemia-reperfusion damage is attenuated by GQ-11, a peroxisome proliferator-activated receptor (PPAR)-α/γ agonist, after aorta clamping in rats (2022)
Silva, Jacqueline Cavalcante ; Bavestrello, Margherita; Gazzola, Valerio; Spinella, Giovanni ; Pane, Bianca; Grasselli, Elena ; Demori, Ilaria; Canesi, Laura ; Emionite, Laura; Cilli, Michele ; Buschiazzo, Ambra; Sambuceti, Gianmario ; Pitta, Ivan Rocha; Pitta, Marina Galdino ; Perego, Patrizia; Perego, Patrizia ; Palombo, Domenico; Abdalla, Dulcinéia Saes Parra
Source: Life Sciences. Unidade: FCF
Subjects: ISQUEMIA, AORTA, ESTRESSE OXIDATIVO, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jacqueline Cavalcante et al. Ischemia-reperfusion damage is attenuated by GQ-11, a peroxisome proliferator-activated receptor (PPAR)-α/γ agonist, after aorta clamping in rats. Life Sciences, v. 297, p. 1-11 art. 120468, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2022.120468. Acesso em: 14 jul. 2024.
APA
Silva, J. C., Bavestrello, M., Gazzola, V., Spinella, G., Pane, B., Grasselli, E., et al. (2022). Ischemia-reperfusion damage is attenuated by GQ-11, a peroxisome proliferator-activated receptor (PPAR)-α/γ agonist, after aorta clamping in rats. Life Sciences, 297, 1-11 art. 120468. doi:10.1016/j.lfs.2022.120468
NLM
Silva JC, Bavestrello M, Gazzola V, Spinella G, Pane B, Grasselli E, Demori I, Canesi L, Emionite L, Cilli M, Buschiazzo A, Sambuceti G, Pitta IR, Pitta MG, Perego P, Perego P, Palombo D, Abdalla DSP. Ischemia-reperfusion damage is attenuated by GQ-11, a peroxisome proliferator-activated receptor (PPAR)-α/γ agonist, after aorta clamping in rats [Internet]. Life Sciences. 2022 ; 297 1-11 art. 120468.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1016/j.lfs.2022.120468
Vancouver
Silva JC, Bavestrello M, Gazzola V, Spinella G, Pane B, Grasselli E, Demori I, Canesi L, Emionite L, Cilli M, Buschiazzo A, Sambuceti G, Pitta IR, Pitta MG, Perego P, Perego P, Palombo D, Abdalla DSP. Ischemia-reperfusion damage is attenuated by GQ-11, a peroxisome proliferator-activated receptor (PPAR)-α/γ agonist, after aorta clamping in rats [Internet]. Life Sciences. 2022 ; 297 1-11 art. 120468.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1016/j.lfs.2022.120468
Artigo de periodico
Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model (2022)
Arora, Aastha ; Tripodi, Gustavo Luis; Kareinen, Ilona ; Berg, Martin; Forteza, Maria Josefa ; Gisterå, Anton ; Griepke, Silke; Casagrande, Felipe Beccaria ; Martins, Joilson de Oliveira ; Abdalla, Dulcinéia Saes Parra ; Cole, Jennifer ; Monaco, Claudia ; Ketelhuth, Daniel Francisco Jacon
Source: Intional Journal of Molecular Sciences. Unidade: FCF
Subjects: ARTERIOSCLEROSE, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARORA, Aastha et al. Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model. Intional Journal of Molecular Sciences, v. 23, p. 1-17 art. 5203, 2022Tradução . . Disponível em: https://doi.org/10.3390/ijms23095203. Acesso em: 14 jul. 2024.
APA
Arora, A., Tripodi, G. L., Kareinen, I., Berg, M., Forteza, M. J., Gisterå, A., et al. (2022). Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model. Intional Journal of Molecular Sciences, 23, 1-17 art. 5203. doi:10.3390/ijms23095203
NLM
Arora A, Tripodi GL, Kareinen I, Berg M, Forteza MJ, Gisterå A, Griepke S, Casagrande FB, Martins J de O, Abdalla DSP, Cole J, Monaco C, Ketelhuth DFJ. Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model [Internet]. Intional Journal of Molecular Sciences. 2022 ; 23 1-17 art. 5203.[citado 2024 jul. 14 ] Available from: https://doi.org/10.3390/ijms23095203
Vancouver
Arora A, Tripodi GL, Kareinen I, Berg M, Forteza MJ, Gisterå A, Griepke S, Casagrande FB, Martins J de O, Abdalla DSP, Cole J, Monaco C, Ketelhuth DFJ. Genetic deficiency of indoleamine 2,3-dioxygenase aggravates vascular but not liver disease in a nonalcoholic steatohepatitis and atherosclerosis comorbidity model [Internet]. Intional Journal of Molecular Sciences. 2022 ; 23 1-17 art. 5203.[citado 2024 jul. 14 ] Available from: https://doi.org/10.3390/ijms23095203
Tese (Doutorado)
Imunização de camundongos LDLr-/- com peptídeo mimético da LDL eletronegativa:: uma potencial estratégia terapêutica para a aterosclerose (2021)
Tripodi, Gustavo Luis; Abdalla, Dulcinéia Saes Parra (Orientador) ; Silveira, Eduardo Lani Volpe da (coorient)
Unidade: FCF
Subjects: ARTERIOSCLEROSE, INFLAMAÇÃO, IMUNIZAÇÃO, PEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TRIPODI, Gustavo Luis. Imunização de camundongos LDLr-/- com peptídeo mimético da LDL eletronegativa:: uma potencial estratégia terapêutica para a aterosclerose. 2021. Tese (Doutorado) – Universidade de São Paulo, São Paulo, 2021. Disponível em: https://www.teses.usp.br/teses/disponiveis/9/9142/tde-04022022-165124/. Acesso em: 14 jul. 2024.
APA
Tripodi, G. L. (2021). Imunização de camundongos LDLr-/- com peptídeo mimético da LDL eletronegativa:: uma potencial estratégia terapêutica para a aterosclerose (Tese (Doutorado). Universidade de São Paulo, São Paulo. Recuperado de https://www.teses.usp.br/teses/disponiveis/9/9142/tde-04022022-165124/
NLM
Tripodi GL. Imunização de camundongos LDLr-/- com peptídeo mimético da LDL eletronegativa:: uma potencial estratégia terapêutica para a aterosclerose [Internet]. 2021 ;[citado 2024 jul. 14 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9142/tde-04022022-165124/
Vancouver
Tripodi GL. Imunização de camundongos LDLr-/- com peptídeo mimético da LDL eletronegativa:: uma potencial estratégia terapêutica para a aterosclerose [Internet]. 2021 ;[citado 2024 jul. 14 ] Available from: https://www.teses.usp.br/teses/disponiveis/9/9142/tde-04022022-165124/
Artigo de periodico
Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione (2021)
Garcia, Giani Martins; Roy, Jérôme; Pitta, Ivan R; Abdalla, Dulcinéia Saes Parra ; Guimarães, Andrea Grabe ; Mosqueira, Vanessa Carla Furtado ; Richard, Sylvain
Source: Pharmaceutics. Unidade: FCF
Subjects: NANOPARTÍCULAS, ARTERIOSCLEROSE, SÍNDROME X METABÓLICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARCIA, Giani Martins et al. Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione. Pharmaceutics, v. 13, p. 1-13 art. 1521, 2021Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics13091521. Acesso em: 14 jul. 2024.
APA
Garcia, G. M., Roy, J., Pitta, I. R., Abdalla, D. S. P., Guimarães, A. G., Mosqueira, V. C. F., & Richard, S. (2021). Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione. Pharmaceutics, 13, 1-13 art. 1521. doi:10.3390/pharmaceutics13091521
NLM
Garcia GM, Roy J, Pitta IR, Abdalla DSP, Guimarães AG, Mosqueira VCF, Richard S. Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione [Internet]. Pharmaceutics. 2021 ; 13 1-13 art. 1521.[citado 2024 jul. 14 ] Available from: https://doi.org/10.3390/pharmaceutics13091521
Vancouver
Garcia GM, Roy J, Pitta IR, Abdalla DSP, Guimarães AG, Mosqueira VCF, Richard S. Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione [Internet]. Pharmaceutics. 2021 ; 13 1-13 art. 1521.[citado 2024 jul. 14 ] Available from: https://doi.org/10.3390/pharmaceutics13091521
Editor de periodico
Brazilian Journal of Pharmaceutical Sciences (2021)
Ferreira, Elizabeth Igne (Editor) ; Rangel-Yagui, Carlota de Oliveira (Editor) ; Serra, Cristina Helena dos Reis (Editor) ; Finardi Filho, Flavio (Editor) ; Martins, Joilson de Oliveira (Editor) ; Gioielli, Luiz Antonio (Editor) ; Vitolo, Michele (Editor); Barros, Silvia Berlanga de Moraes (Editor) ; Storpirtis, Silvia (Editor) ; Maria-Engler, Silvya Stuchi (Editor) ; Consiglieri, Vladi Olga (Editor) ; Andricopulo, Adriano Defini (Editor) ; Midio, Antonio Flavio (Editor); Salatino, Antonio (Editor) ; Abdalla, Dulcinéia Saes Parra (Editor) ; Lajolo, Franco Maria (Editor) ; Lopes, João Luis Callegari (Editor) ; Mancini-Filho, Jorge (Editor) ; Santoro, Maria Inês Rocha Miritello (Editor); Penteado, Marilene de Vuono Camargo (Editor); Yoshida, Massayoshi (Editor); Curi, Rui (Editor) ; Oga, Seizi (Editor); Vilela, Sueli (Editor)
Unidades: FCF, IFSC, IB, FCFRP, IQ
Assunto: FARMÁCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Brazilian Journal of Pharmaceutical Sciences. . São Paulo: Universidade de São Paulo - USP. . Acesso em: 14 jul. 2024. , 2021
APA
Brazilian Journal of Pharmaceutical Sciences. (2021). Brazilian Journal of Pharmaceutical Sciences. São Paulo: Universidade de São Paulo - USP.
NLM
Brazilian Journal of Pharmaceutical Sciences. 2021 ;[citado 2024 jul. 14 ]
Vancouver
Brazilian Journal of Pharmaceutical Sciences. 2021 ;[citado 2024 jul. 14 ]
Artigo de periodico
scFv-Anti-LDL(-)-metal-complex multi-wall functionalized-nanocapsules as a promising tool for the prevention of atherosclerosis progression (2021)
Cavalcante, Marcela Frota; Adorne, Márcia Duarte; Turato, Walter Miguel; Kemmerer, Marina; Uchiyama, Mayara Klimuk ; Asbahr, Ana Carolina Cavazzin; Alves, Aline de Cristo Soares; Farsky, Sandra Helena Poliselli ; Drewes, Carine; Spatti, Marina Cecília; Kazuma, Soraya Megumi; Boss, Marcel; Guterres, Silvia Stanisçuaski ; Araki, Koiti ; Brüne, Bernhard; Namgaladze, Dmitry; Pohlmann, Adriana Raffin ; Abdalla, Dulcinéia Saes Parra
Source: Frontiers in Medicine. Unidades: FCF, IQ
Subjects: ARTERIOSCLEROSE, LIPOPROTEÍNAS LDL, NANOTECNOLOGIA, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAVALCANTE, Marcela Frota et al. scFv-Anti-LDL(-)-metal-complex multi-wall functionalized-nanocapsules as a promising tool for the prevention of atherosclerosis progression. Frontiers in Medicine, v. 8, p. 1-14 art. 652137, 2021Tradução . . Disponível em: https://doi.org/10.3389/fmed.2021.652137. Acesso em: 14 jul. 2024.
APA
Cavalcante, M. F., Adorne, M. D., Turato, W. M., Kemmerer, M., Uchiyama, M. K., Asbahr, A. C. C., et al. (2021). scFv-Anti-LDL(-)-metal-complex multi-wall functionalized-nanocapsules as a promising tool for the prevention of atherosclerosis progression. Frontiers in Medicine, 8, 1-14 art. 652137. doi:10.3389/fmed.2021.652137
NLM
Cavalcante MF, Adorne MD, Turato WM, Kemmerer M, Uchiyama MK, Asbahr ACC, Alves A de CS, Farsky SHP, Drewes C, Spatti MC, Kazuma SM, Boss M, Guterres SS, Araki K, Brüne B, Namgaladze D, Pohlmann AR, Abdalla DSP. scFv-Anti-LDL(-)-metal-complex multi-wall functionalized-nanocapsules as a promising tool for the prevention of atherosclerosis progression [Internet]. Frontiers in Medicine. 2021 ; 8 1-14 art. 652137.[citado 2024 jul. 14 ] Available from: https://doi.org/10.3389/fmed.2021.652137
Vancouver
Cavalcante MF, Adorne MD, Turato WM, Kemmerer M, Uchiyama MK, Asbahr ACC, Alves A de CS, Farsky SHP, Drewes C, Spatti MC, Kazuma SM, Boss M, Guterres SS, Araki K, Brüne B, Namgaladze D, Pohlmann AR, Abdalla DSP. scFv-Anti-LDL(-)-metal-complex multi-wall functionalized-nanocapsules as a promising tool for the prevention of atherosclerosis progression [Internet]. Frontiers in Medicine. 2021 ; 8 1-14 art. 652137.[citado 2024 jul. 14 ] Available from: https://doi.org/10.3389/fmed.2021.652137
Parte de monografia/livro
Radicais livres e antioxidantes (2021)
Abdalla, Dulcinéia Saes Parra ; Faine, Luciane Aparecida; Loureiro, Ana Paula de Melo
Source: Fundamentos de Toxicologia. Unidade: FCF
Subjects: RADICAIS LIVRES, ANTIOXIDANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABDALLA, Dulcinéia Saes Parra e FAINE, Luciane Aparecida e LOUREIRO, Ana Paula de Melo. Radicais livres e antioxidantes. Fundamentos de Toxicologia. Tradução . São Paulo: Atheneu, 2021. . . Acesso em: 14 jul. 2024.
APA
Abdalla, D. S. P., Faine, L. A., & Loureiro, A. P. de M. (2021). Radicais livres e antioxidantes. In Fundamentos de Toxicologia. São Paulo: Atheneu.
NLM
Abdalla DSP, Faine LA, Loureiro AP de M. Radicais livres e antioxidantes. In: Fundamentos de Toxicologia. São Paulo: Atheneu; 2021. [citado 2024 jul. 14 ]
Vancouver
Abdalla DSP, Faine LA, Loureiro AP de M. Radicais livres e antioxidantes. In: Fundamentos de Toxicologia. São Paulo: Atheneu; 2021. [citado 2024 jul. 14 ]
Artigo de periodico
Histological evaluation and gene expression profiling of autophagy-related genes for cartilage of young and senescent rats (2020)
Arias, Consuelo ; Saavedra, Nicolás ; Leal, Karla; Vásquez, Bélgica; Abdalla, Dulcinéia Saes Parra ; Salazar, Luis A
Source: International Journal of Molecular Sciences. Unidade: FCF
Subjects: OSTEOARTRITE, ENVELHECIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARIAS, Consuelo et al. Histological evaluation and gene expression profiling of autophagy-related genes for cartilage of young and senescent rats. International Journal of Molecular Sciences, v. 21, p. 1-15 art. 8607, 2020Tradução . . Disponível em: https://doi.org/10.3390/ijms21228607. Acesso em: 14 jul. 2024.
APA
Arias, C., Saavedra, N., Leal, K., Vásquez, B., Abdalla, D. S. P., & Salazar, L. A. (2020). Histological evaluation and gene expression profiling of autophagy-related genes for cartilage of young and senescent rats. International Journal of Molecular Sciences, 21, 1-15 art. 8607. doi:10.3390/ijms21228607
NLM
Arias C, Saavedra N, Leal K, Vásquez B, Abdalla DSP, Salazar LA. Histological evaluation and gene expression profiling of autophagy-related genes for cartilage of young and senescent rats [Internet]. International Journal of Molecular Sciences. 2020 ; 21 1-15 art. 8607.[citado 2024 jul. 14 ] Available from: https://doi.org/10.3390/ijms21228607
Vancouver
Arias C, Saavedra N, Leal K, Vásquez B, Abdalla DSP, Salazar LA. Histological evaluation and gene expression profiling of autophagy-related genes for cartilage of young and senescent rats [Internet]. International Journal of Molecular Sciences. 2020 ; 21 1-15 art. 8607.[citado 2024 jul. 14 ] Available from: https://doi.org/10.3390/ijms21228607
Artigo de periodico
Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters (2020)
Almeida, Anderson Rodrigues de; Dantas, Andréa Tavares; Pereira, Michelly Cristiny; Rêgo, Moacyr Jesus Barreto de Melo; Gonçalves, Rafaela Silva Guimarães; Pitta, Ivan da Rocha; Duarte, Angela Luzia Branco Pinto; Abdalla, Dulcinéia Saes Parra ; Pitta, Maira Galdino da Rocha
Source: Immunobiology. Unidade: FCF
Subjects: CITOCINAS, AUTOIMUNIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Anderson Rodrigues de et al. Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters. Immunobiology, v. 225, p. 1-12, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.imbio.2020.15196. Acesso em: 14 jul. 2024.
APA
Almeida, A. R. de, Dantas, A. T., Pereira, M. C., Rêgo, M. J. B. de M., Gonçalves, R. S. G., Pitta, I. da R., et al. (2020). Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters. Immunobiology, 225, 1-12. doi:10.1016/j.imbio.2020.15196
NLM
Almeida AR de, Dantas AT, Pereira MC, Rêgo MJB de M, Gonçalves RSG, Pitta I da R, Duarte ALBP, Abdalla DSP, Pitta MG da R. Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters [Internet]. Immunobiology. 2020 ; 225 1-12.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1016/j.imbio.2020.15196
Vancouver
Almeida AR de, Dantas AT, Pereira MC, Rêgo MJB de M, Gonçalves RSG, Pitta I da R, Duarte ALBP, Abdalla DSP, Pitta MG da R. Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters [Internet]. Immunobiology. 2020 ; 225 1-12.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1016/j.imbio.2020.15196
Artigo de periodico
Prodigiosin modulates the immune response and could promote a stable atherosclerotic lession in C57bl/6 Ldlr-/- Mice (2020)
Cuevas, Alejandro ; Saavedra, Nicolás ; Salazar, Luis A; Cavalcante, Marcela Frota; Silva, Jacqueline Cavalcante ; Abdalla, Dulcinéia Saes Parra
Source: International Journal of Molecular Sciences. Unidade: FCF
Subjects: ARTERIOSCLEROSE, METABÓLITOS SECUNDÁRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUEVAS, Alejandro et al. Prodigiosin modulates the immune response and could promote a stable atherosclerotic lession in C57bl/6 Ldlr-/- Mice. International Journal of Molecular Sciences, v. 21, p. 1-18 art. 6417, 2020Tradução . . Disponível em: https://doi.org/10.3390/ijms21176417. Acesso em: 14 jul. 2024.
APA
Cuevas, A., Saavedra, N., Salazar, L. A., Cavalcante, M. F., Silva, J. C., & Abdalla, D. S. P. (2020). Prodigiosin modulates the immune response and could promote a stable atherosclerotic lession in C57bl/6 Ldlr-/- Mice. International Journal of Molecular Sciences, 21, 1-18 art. 6417. doi:10.3390/ijms21176417
NLM
Cuevas A, Saavedra N, Salazar LA, Cavalcante MF, Silva JC, Abdalla DSP. Prodigiosin modulates the immune response and could promote a stable atherosclerotic lession in C57bl/6 Ldlr-/- Mice [Internet]. International Journal of Molecular Sciences. 2020 ; 21 1-18 art. 6417.[citado 2024 jul. 14 ] Available from: https://doi.org/10.3390/ijms21176417
Vancouver
Cuevas A, Saavedra N, Salazar LA, Cavalcante MF, Silva JC, Abdalla DSP. Prodigiosin modulates the immune response and could promote a stable atherosclerotic lession in C57bl/6 Ldlr-/- Mice [Internet]. International Journal of Molecular Sciences. 2020 ; 21 1-18 art. 6417.[citado 2024 jul. 14 ] Available from: https://doi.org/10.3390/ijms21176417
Editor de periodico
Brazilian Journal of Pharmaceutical Sciences (2020)
Ferreira, Elizabeth Igne (Editor) ; Rangel-Yagui, Carlota de Oliveira (Editor) ; Serra, Cristina Helena dos Reis (Editor) ; Finardi Filho, Flavio (Editor) ; Martins, Joilson de Oliveira (Editor) ; Gioielli, Luiz Antonio (Editor) ; Vitolo, Michele (Editor); Barros, Silvia Berlanga de Moraes (Editor) ; Storpirtis, Silvia (Editor) ; Maria-Engler, Silvya Stuchi (Editor) ; Consiglieri, Vladi Olga (Editor) ; Andricopulo, Adriano Defini (Editor) ; Midio, Antonio Flavio (Editor); Salatino, Antonio (Editor) ; Abdalla, Dulcinéia Saes Parra (Editor) ; Lajolo, Franco Maria (Editor) ; Lopes, João Luis Callegari (Editor); Mancini-Filho, Jorge (Editor) ; Santoro, Maria Inês Rocha Miritello (Editor); Penteado, Marilene de Vuono Camargo (Editor); Yoshida, Massayoshi (Editor); Curi, Rui (Editor); Oga, Seizi (Editor); Vilela, Sueli (Editor)
Unidades: FCF, IFSC, IB, FCFRP, IQ
Assunto: FARMÁCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Brazilian Journal of Pharmaceutical Sciences. . São Paulo: Universidade de São Paulo - USP. . Acesso em: 14 jul. 2024. , 2020
APA
Brazilian Journal of Pharmaceutical Sciences. (2020). Brazilian Journal of Pharmaceutical Sciences. São Paulo: Universidade de São Paulo - USP.
NLM
Brazilian Journal of Pharmaceutical Sciences. 2020 ;[citado 2024 jul. 14 ]
Vancouver
Brazilian Journal of Pharmaceutical Sciences. 2020 ;[citado 2024 jul. 14 ]
Artigo de periodico
Inflammasome activation in human macrophages induced by a LDL (−) mimetic peptide (2020)
Tripodi, Gustavo Luis; Prieto, Marcela Bach; Abdalla, Dulcinéia Saes Parra
Source: Inflammation. Unidade: FCF
Subjects: MACRÓFAGOS, PEPTÍDEOS, INTERLEUCINAS, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TRIPODI, Gustavo Luis e PRIETO, Marcela Bach e ABDALLA, Dulcinéia Saes Parra. Inflammasome activation in human macrophages induced by a LDL (−) mimetic peptide. Inflammation, v. 43, n. 2 p. 722-730, 2020Tradução . . Disponível em: https://doi.org/10.1007/s10753-019-01159-y. Acesso em: 14 jul. 2024.
APA
Tripodi, G. L., Prieto, M. B., & Abdalla, D. S. P. (2020). Inflammasome activation in human macrophages induced by a LDL (−) mimetic peptide. Inflammation, 43( 2 p. 722-730). doi:10.1007/s10753-019-01159-y
NLM
Tripodi GL, Prieto MB, Abdalla DSP. Inflammasome activation in human macrophages induced by a LDL (−) mimetic peptide [Internet]. Inflammation. 2020 ; 43( 2 p. 722-730):[citado 2024 jul. 14 ] Available from: https://doi.org/10.1007/s10753-019-01159-y
Vancouver
Tripodi GL, Prieto MB, Abdalla DSP. Inflammasome activation in human macrophages induced by a LDL (−) mimetic peptide [Internet]. Inflammation. 2020 ; 43( 2 p. 722-730):[citado 2024 jul. 14 ] Available from: https://doi.org/10.1007/s10753-019-01159-y
Artigo de periodico
New peroxisome proliferator-activated receptor agonist (GQ-11) improves wound healing in diabetic mice (2019)
Silva, Jacqueline C; Pitta, Marina G. R; Pitta, Ivan R; Koh, Timothy Jon; Abdalla, Dulcinéia Saes Parra
Source: Advances in Wound Care. Unidade: FCF
Subjects: BIOLOGIA CELULAR, DIABETES MELLITUS, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jacqueline C et al. New peroxisome proliferator-activated receptor agonist (GQ-11) improves wound healing in diabetic mice. Advances in Wound Care, v. 8, n. 9, p. 417-428, 2019Tradução . . Disponível em: https://doi.org/10.1089/wound.2018.0911. Acesso em: 14 jul. 2024.
APA
Silva, J. C., Pitta, M. G. R., Pitta, I. R., Koh, T. J., & Abdalla, D. S. P. (2019). New peroxisome proliferator-activated receptor agonist (GQ-11) improves wound healing in diabetic mice. Advances in Wound Care, 8( 9), 417-428. doi:10.1089/wound.2018.0911
NLM
Silva JC, Pitta MGR, Pitta IR, Koh TJ, Abdalla DSP. New peroxisome proliferator-activated receptor agonist (GQ-11) improves wound healing in diabetic mice [Internet]. Advances in Wound Care. 2019 ; 8( 9): 417-428.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1089/wound.2018.0911
Vancouver
Silva JC, Pitta MGR, Pitta IR, Koh TJ, Abdalla DSP. New peroxisome proliferator-activated receptor agonist (GQ-11) improves wound healing in diabetic mice [Internet]. Advances in Wound Care. 2019 ; 8( 9): 417-428.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1089/wound.2018.0911
Tese (Doutorado)
Effects of a new thiazolidine compound (GQ-11) on tissue repair process in models of insulin resistance and ischemia-reperfusion (2019)
Silva, Jacqueline Cavalcante; Abdalla, Dulcinéia Saes Parra (Orientador) ; Perego, Patrizia (Orientador)
Unidade: FCF
Subjects: DIABETES MELLITUS, INFLAMAÇÃO, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jacqueline Cavalcante. Effects of a new thiazolidine compound (GQ-11) on tissue repair process in models of insulin resistance and ischemia-reperfusion. 2019. Tese (Doutorado) – Universidade de São Paulo, São Paulo, 2019. Disponível em: http://www.teses.usp.br/teses/disponiveis/9/9142/tde-03122019-115921/. Acesso em: 14 jul. 2024.
APA
Silva, J. C. (2019). Effects of a new thiazolidine compound (GQ-11) on tissue repair process in models of insulin resistance and ischemia-reperfusion (Tese (Doutorado). Universidade de São Paulo, São Paulo. Recuperado de http://www.teses.usp.br/teses/disponiveis/9/9142/tde-03122019-115921/
NLM
Silva JC. Effects of a new thiazolidine compound (GQ-11) on tissue repair process in models of insulin resistance and ischemia-reperfusion [Internet]. 2019 ;[citado 2024 jul. 14 ] Available from: http://www.teses.usp.br/teses/disponiveis/9/9142/tde-03122019-115921/
Vancouver
Silva JC. Effects of a new thiazolidine compound (GQ-11) on tissue repair process in models of insulin resistance and ischemia-reperfusion [Internet]. 2019 ;[citado 2024 jul. 14 ] Available from: http://www.teses.usp.br/teses/disponiveis/9/9142/tde-03122019-115921/
Editor de periodico
Brazilian Journal of Pharmaceutical Sciences (2019)
Ferreira, Elizabeth Igne (Editor) ; Rangel-Yagui, Carlota de Oliveira (Editor) ; Serra, Cristina Helena dos Reis (Editor) ; Finardi Filho, Flavio (Editor) ; Martins, Joilson de Oliveira (Editor) ; Gioielli, Luiz Antonio (Editor) ; Vitolo, Michele (Editor); Barros, Silvia Berlanga de Moraes (Editor) ; Storpirtis, Silvia (Editor) ; Maria-Engler, Silvya Stuchi (Editor) ; Consiglieri, Vladi Olga (Editor) ; Andricopulo, Adriano Defini (Editor); Midio, Antonio Flavio (Editor); Salatino, Antonio (Editor) ; Abdalla, Dulcinéia Saes Parra (Editor) ; Lajolo, Franco Maria (Editor) ; Lopes, João Luis Callegari (Editor); Mancini-Filho, Jorge (Editor) ; Santoro, Maria Inês Rocha Miritello (Editor); Penteado, Marilene de Vuono Camargo (Editor); Yoshida, Massayoshi (Editor); Curi, Rui (Editor); Oga, Seizi (Editor); Vilela, Sueli (Editor)
Source: Brazilian Journal of Pharmaceutical Sciences. Unidades: FCF, IFSC, IB, FCFRP, IQ, ICB
Assunto: FARMÁCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
Brazilian Journal of Pharmaceutical Sciences. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Universidade de São Paulo - USP, Faculdade de Ciências Farmacêuticas - FCF. . Acesso em: 14 jul. 2024. , 2019
APA
Brazilian Journal of Pharmaceutical Sciences. (2019). Brazilian Journal of Pharmaceutical Sciences. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Universidade de São Paulo - USP, Faculdade de Ciências Farmacêuticas - FCF.
NLM
Brazilian Journal of Pharmaceutical Sciences. Brazilian Journal of Pharmaceutical Sciences. 2019 ;[citado 2024 jul. 14 ]
Vancouver
Brazilian Journal of Pharmaceutical Sciences. Brazilian Journal of Pharmaceutical Sciences. 2019 ;[citado 2024 jul. 14 ]
Artigo de periodico
Proinflammatory action of a new electronegative low-density lipoprotein epitope (2019)
Faulin, Tanize do Espírito Santo; Kazuma, Soraya Megumi; Tripodi, Gustavo Luis; Cavalcante, Marcela Frota; Wakasuqui, Felipe; Oliveira, Cristiano Luis Pinto de; Degenhardt, Maximilia Frazão de Souza; Michaloski, Jussara; Giordano, Ricardo José ; Ketelhuth, Daniel Francisco Jacon; Abdalla, Dulcinéia Saes Parra
Source: Biomolecules. Unidades: IF, IQ, FCF
Subjects: ARTERIOSCLEROSE, MACRÓFAGOS, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAULIN, Tanize do Espírito Santo et al. Proinflammatory action of a new electronegative low-density lipoprotein epitope. Biomolecules, v. 9, n. 8, p. 1-17 art. 386, 2019Tradução . . Disponível em: https://doi.org/10.3390/biom9080386. Acesso em: 14 jul. 2024.
APA
Faulin, T. do E. S., Kazuma, S. M., Tripodi, G. L., Cavalcante, M. F., Wakasuqui, F., Oliveira, C. L. P. de, et al. (2019). Proinflammatory action of a new electronegative low-density lipoprotein epitope. Biomolecules, 9( 8), 1-17 art. 386. doi:10.3390/biom9080386
NLM
Faulin T do ES, Kazuma SM, Tripodi GL, Cavalcante MF, Wakasuqui F, Oliveira CLP de, Degenhardt MF de S, Michaloski J, Giordano RJ, Ketelhuth DFJ, Abdalla DSP. Proinflammatory action of a new electronegative low-density lipoprotein epitope [Internet]. Biomolecules. 2019 ; 9( 8): 1-17 art. 386.[citado 2024 jul. 14 ] Available from: https://doi.org/10.3390/biom9080386
Vancouver
Faulin T do ES, Kazuma SM, Tripodi GL, Cavalcante MF, Wakasuqui F, Oliveira CLP de, Degenhardt MF de S, Michaloski J, Giordano RJ, Ketelhuth DFJ, Abdalla DSP. Proinflammatory action of a new electronegative low-density lipoprotein epitope [Internet]. Biomolecules. 2019 ; 9( 8): 1-17 art. 386.[citado 2024 jul. 14 ] Available from: https://doi.org/10.3390/biom9080386
Artigo de periodico
Influence of carbon source on cell size and production of anti LDL (-) single-chain variable fragment by a recombinant Pichia pastoris strain (2019)
Arias, Cesar Andres Diaz; Molino, João Vitor Dutra ; Marques, Daniela de Araújo Viana ; Maranhão, Andréa Queiroz ; Abdalla, Dulcinéia Saes Parra ; Pessoa Junior, Adalberto ; Converti, Attilio
Source: Molecular Biology Reports. Unidade: FCF
Subjects: ENZIMAS, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARIAS, Cesar Andres Diaz et al. Influence of carbon source on cell size and production of anti LDL (-) single-chain variable fragment by a recombinant Pichia pastoris strain. Molecular Biology Reports, v. 46, n. 3, p. 3257-3264, 2019Tradução . . Disponível em: https://doi.org/10.1007/s11033-019-04785-9. Acesso em: 14 jul. 2024.
APA
Arias, C. A. D., Molino, J. V. D., Marques, D. de A. V., Maranhão, A. Q., Abdalla, D. S. P., Pessoa Junior, A., & Converti, A. (2019). Influence of carbon source on cell size and production of anti LDL (-) single-chain variable fragment by a recombinant Pichia pastoris strain. Molecular Biology Reports, 46( 3), 3257-3264. doi:10.1007/s11033-019-04785-9
NLM
Arias CAD, Molino JVD, Marques D de AV, Maranhão AQ, Abdalla DSP, Pessoa Junior A, Converti A. Influence of carbon source on cell size and production of anti LDL (-) single-chain variable fragment by a recombinant Pichia pastoris strain [Internet]. Molecular Biology Reports. 2019 ; 46( 3): 3257-3264.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1007/s11033-019-04785-9
Vancouver
Arias CAD, Molino JVD, Marques D de AV, Maranhão AQ, Abdalla DSP, Pessoa Junior A, Converti A. Influence of carbon source on cell size and production of anti LDL (-) single-chain variable fragment by a recombinant Pichia pastoris strain [Internet]. Molecular Biology Reports. 2019 ; 46( 3): 3257-3264.[citado 2024 jul. 14 ] Available from: https://doi.org/10.1007/s11033-019-04785-9
Artigo de periodico
Use of nPSi-βCD composite microparticles for the controlled release of caffeic acid and pinocembrin, two main polyphenolic compounds found in a chilean propolis (2019)
Oyarzo, Dina Guzmán; Plaza, Tanya; Sánchez, Gonzalo Recio; Abdalla, Dulcinéia Saes Parra ; Salazar, Luis A; Montelongo, Jacobo Hernández
Source: Pharmaceutics. Unidade: FCF
Subjects: PRÓPOLIS, POLIFENÓIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OYARZO, Dina Guzmán et al. Use of nPSi-βCD composite microparticles for the controlled release of caffeic acid and pinocembrin, two main polyphenolic compounds found in a chilean propolis. Pharmaceutics, v. 11, p. 1-17 art. 289, 2019Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics11060289. Acesso em: 14 jul. 2024.
APA
Oyarzo, D. G., Plaza, T., Sánchez, G. R., Abdalla, D. S. P., Salazar, L. A., & Montelongo, J. H. (2019). Use of nPSi-βCD composite microparticles for the controlled release of caffeic acid and pinocembrin, two main polyphenolic compounds found in a chilean propolis. Pharmaceutics, 11, 1-17 art. 289. doi:10.3390/pharmaceutics11060289
NLM
Oyarzo DG, Plaza T, Sánchez GR, Abdalla DSP, Salazar LA, Montelongo JH. Use of nPSi-βCD composite microparticles for the controlled release of caffeic acid and pinocembrin, two main polyphenolic compounds found in a chilean propolis [Internet]. Pharmaceutics. 2019 ; 11 1-17 art. 289.[citado 2024 jul. 14 ] Available from: https://doi.org/10.3390/pharmaceutics11060289
Vancouver
Oyarzo DG, Plaza T, Sánchez GR, Abdalla DSP, Salazar LA, Montelongo JH. Use of nPSi-βCD composite microparticles for the controlled release of caffeic acid and pinocembrin, two main polyphenolic compounds found in a chilean propolis [Internet]. Pharmaceutics. 2019 ; 11 1-17 art. 289.[citado 2024 jul. 14 ] Available from: https://doi.org/10.3390/pharmaceutics11060289

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration

Sigla do Departamento/Programa de Pós Graduação

Departamento/Programa de Pós Graduação